MedPath
HSA Approval

PANTONEX DR-40 TABLET 40MG

SIN14467P

PANTONEX DR-40 TABLET 40MG

PANTONEX DR-40 TABLET 40MG

December 23, 2013

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, DELAYED RELEASE

ORAL

Medical Information

A02BC02

pantoprazole

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

IPCA LABORATORIES LIMITED

Active Ingredients

Pantoprazole sodium Sesquihydrate 45.11mg equivalent to Pantoprazole

40 mg

Pantoprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.